Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas (FLT-Oss-2015)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02927756
Recruitment Status : Recruiting
First Posted : October 7, 2016
Last Update Posted : November 24, 2017
Sponsor:
Information provided by (Responsible Party):
Barbara Botto, Azienda Ospedaliera Città della Salute e della Scienza di Torino

Brief Summary:
Study purpose is to evaluate treatment outcome and survival in patient with aggressive lymphomas transformed from Follicular Lymphoma.

Condition or disease
Non-Hodgkin Lymphoma Transformed Recurrent

Layout table for study information
Study Type : Observational
Estimated Enrollment : 180 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
Estimated Study Start Date : November 2017
Estimated Primary Completion Date : May 2018
Estimated Study Completion Date : June 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lymphoma




Primary Outcome Measures :
  1. Progression Free Survival [ Time Frame: From first response to last follow-up for at least 2 years (up to 15 years) ]
    Time from last response to nearest relapse or follow-up

  2. Overall Survival [ Time Frame: Date of last follow-up for at least 2 years (up to 15 years) ]
    Time to last follow-up or death



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patient with histologically confirmed diagnosis of Transformed Follicular Lymphoma
Criteria

Inclusion Criteria:

  • Histologically confirmed transformed Follicular Lymphoma
  • Age > 18 years
  • Histological transformation between January 2002 and December 2014
  • Availability of data about treatment and outcome

Exclusion Criteria:

  • Other lymphoma diagnosis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02927756


Contacts
Layout table for location contacts
Contact: Barbara Botto, MD +390116334553 bbotto@cittadellasalute.to.it

Locations
Layout table for location information
Italy
SC Ematologia - AOU Città della Salute e della Scienza di Torino Recruiting
Torino, Italy, 10126
Contact: Barbara Botto, MD    +390116331    bbotto@cittadellasalute.to.it   
Sponsors and Collaborators
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Investigators
Layout table for investigator information
Principal Investigator: Barbara Botto, MD AOU Città della Salute e della Scienza di Torino

Layout table for additonal information
Responsible Party: Barbara Botto, MD, Azienda Ospedaliera Città della Salute e della Scienza di Torino
ClinicalTrials.gov Identifier: NCT02927756     History of Changes
Other Study ID Numbers: FLT-Oss-2015
First Posted: October 7, 2016    Key Record Dates
Last Update Posted: November 24, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: paper publication

Keywords provided by Barbara Botto, Azienda Ospedaliera Città della Salute e della Scienza di Torino:
Non-Hodgkin Lymphoma Transformed Recurrent
Discordant Lymphomas
Composite Lymphomas
Follicular Lymphoma
Aggressive Lymphoma

Additional relevant MeSH terms:
Layout table for MeSH terms
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases